NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
Clinical Trials
11 trialsNCT01999179 2022-05-18
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
Phase NA Completed
NCT02706249 2021-07-08
Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00633061 2020-10-08
DVT
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT01763606 2020-08-14
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT02366871 2020-03-31
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
Phase 2 Completed
NCT02589145 2019-12-13
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT01696760 2018-12-05
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT01965002 2018-05-23
Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
Stanford University
Phase NA Terminated
NCT00426127 2017-12-29
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
University of Iowa
Phase 2 Terminated
NCT00908960 2017-12-19
MicroTEC
Dana-Farber Cancer Institute
Phase 2 Completed